http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#Head
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#assertion
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#provenance
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#pubinfo
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#assertion
https://uts.nlm.nih.gov/uts/umls/concept/C0012634
http://wordnet-rdf.princeton.edu/lemma/modifying
https://uts.nlm.nih.gov/uts/umls/concept/C0242708
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#provenance
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#_assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC Project - version 4
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#_assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC version 3
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#_version
http://www.w3.org/ns/prov#value
2
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#assertion
http://www.w3.org/ns/prov#generatedAtTime
2023-07-20T09:47:08.940397
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0003-4692-1377
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
https://doi.org/10.1007/s10067-021-05743-2
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT
http://www.w3.org/2000/01/rdf-schema#label
anti-rheumatic drugs ( DMARDs )
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
(53, 60)
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE
http://www.w3.org/2000/01/rdf-schema#label
modifying
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION
http://www.w3.org/2000/01/rdf-schema#label
61, 70
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT
http://www.w3.org/2000/01/rdf-schema#label
disease
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
(53, 60)
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://www.w3.org/2000/01/rdf-schema#label
The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs) is an evolving area.
http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID
http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:fcy3fn4c&rows=50
fcy3fn4c
http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID
http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:fcy3fn4c-TRIPLE-ABSTRACT-1
fcy3fn4c-TRIPLE-ABSTRACT-1
https://uts.nlm.nih.gov/uts/umls/concept/C0012634
http://www.w3.org/2000/01/rdf-schema#label
disease
https://uts.nlm.nih.gov/uts/umls/concept/C0242708
http://www.w3.org/2000/01/rdf-schema#label
dmards
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#pubinfo
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#sig
http://purl.org/nanopub/x/hasPublicKey
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
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#sig
http://purl.org/nanopub/x/hasSignature
SU2zbjxdiHIPSFUdUCcvRBlT+aMbNzPoyS8Wl/GQnuW8Ha0Usw3lG9oji94SU3pZ/1b+i5nZSFocmR/TRJv01Nqht//fZcoNUJ8+MY7+RKuKyWSmBWSDuWpIwt1A9XXy15yEgApQgtUAk66bfDr6KqQBv6DivA6g/PKcdbf5zPn2RWiOOOSugVMlvD5Cdj/GuwHZR4lfBGCvJm22aU+lP9roJ5NAnKxCvDMJ2GcnE0RvxyefBgSAiDz0tKkf2BIsVEMXvk6CGxJdd7XglE/CNH9SQUIa0iSCNimx+Xt9rDUIcrX55JNMHILb7K9og2z+6u5G9ybSeiN4qKoQQlNbv6YUwE3IRAHEdE7gAdBOhn8HoaHoMHG7YkdzXGmAP4S6+8+V/eyA2qBdqOg43O+O7mgpqHLbiNNKa6mJybeEPaMKp4WvDbJ6prhun14FRkD+7fLqXpCdIxr4Jv6o3c98am1daE6gp1mrVtsCP20BzU1vEFLf3s9dNWOZ59jZWZR7
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://purl.org/np/RANIZiVFd3yUMuU6hoWU6f1COIfMCph33sh41uQtQnhAA
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0003-4692-1377